Published in Blood on May 01, 1991
Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. Transfusion (2010) 0.90
An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. J Clin Invest (1992) 0.86
A molecular evolutionary framework for the phylum Nematoda. Nature (1998) 10.64
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med (1995) 4.75
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med (1998) 3.98
Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev (2001) 3.59
A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr Biol (2001) 3.30
Large-scale taxonomic profiling of eukaryotic model organisms: a comparison of orthologous proteins encoded by the human, fly, nematode, and yeast genomes. Genome Res (1998) 2.60
Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med (1982) 2.57
Should all pregnant women be tested for their platelet PLA (Zw, HPA-1) phenotype? Br J Haematol (1994) 2.06
The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med (1988) 1.98
Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest (1969) 1.93
Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost (2001) 1.93
Autoimmune thrombocytopenic purpura. Blood (1980) 1.92
Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest (1969) 1.88
On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med (1984) 1.87
Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J Virol (1999) 1.79
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab (2012) 1.78
Autoimmune thrombocytopenic purpura. Semin Hematol (1985) 1.74
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol (2001) 1.69
Thalassemia intermedia and recurrent priapism following splenectomy. Haematologica (1991) 1.64
Production of methanethiol from methionine by Brevibacterium linens CNRZ 918. J Gen Microbiol (1985) 1.63
Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci U S A (1999) 1.62
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum (2001) 1.60
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost (2003) 1.55
Enteritis, eosinophilia, and Enterobius vermicularis. Lancet (1995) 1.55
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1994) 1.52
Human ehrlichiosis in New England. N Engl J Med (1994) 1.48
Role of platelets in tumor cell metastases. Ann Intern Med (1981) 1.46
Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood (1998) 1.42
Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis. J Clin Invest (1967) 1.41
Pupillary enlargement caused by an acute extradural haematoma associated with a non-symptomatic arachnoid cyst, from compression of the optic rather than the oculomotor nerve. Br J Neurosurg (1999) 1.39
Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res (1992) 1.38
Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood (1978) 1.37
Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer. Bone Marrow Transplant (2004) 1.37
Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest (1991) 1.36
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Use of the megathrombocyte as an index of megakaryocyte number. N Engl J Med (1971) 1.35
Thrombocytopenic purpura in narcotics addicts. Ann Intern Med (1985) 1.33
Biochemical and genetic characterization of PepF, an oligopeptidase from Lactococcus lactis. J Biol Chem (1994) 1.32
Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med (1998) 1.28
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell (2001) 1.26
Biochemical energetics of simulated platelet plug formation. Effect of thrombin, adenosine diphosphate, and epinephrine on intra- and extracellular adenine nucleotide kinetics. J Clin Invest (1968) 1.26
Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. J Clin Microbiol (1987) 1.25
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab (2001) 1.23
Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A (1988) 1.23
Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost (1995) 1.22
Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.22
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A (1997) 1.21
Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost (2000) 1.20
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Anterior suspended flaps: a modified approach for external dacryocystorhinostomy. Br J Ophthalmol (1998) 1.19
Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation. Virology (1996) 1.17
A solid-phase radioimmunoassay for bound anti-platelet antibody: studies on 45 patients with autoimmune platelet disorders. J Lab Clin Med (1979) 1.16
Antiplatelet treatment of thrombotic thrombocytopenic purpura. Ann Intern Med (1977) 1.14
Biochemical and biophysical aspects of human platelet adhesion to collagen fibers. J Clin Invest (1971) 1.14
Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res (1984) 1.14
Bancroftian filariasis and ivermectin. N Engl J Med (1990) 1.11
Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol (1997) 1.08
Cloning and sequencing of pepC, a cysteine aminopeptidase gene from Lactococcus lactis subsp. cremoris AM2. Appl Environ Microbiol (1993) 1.06
Role of platelets in tumor cell metastases. Ann N Y Acad Sci (1981) 1.05
Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood (2000) 1.04
Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem (2000) 1.03
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci U S A (1980) 1.03
A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer (1999) 1.03
Crossed immunoelectrophoresis of human platelet membranes. The major antigen consists of a complex of glycoproteins, GPIIb and GPIIIa, held together by Ca2+ and missing in Glanzmann's thrombasthenia. J Biol Chem (1982) 1.03
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med (1972) 1.03
Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest (1986) 1.02
Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer (1993) 1.01
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br J Ophthalmol (2008) 1.01
Free-floating cyst in the anterior chamber: ultrasound biomicroscopic reports. Eur J Ophthalmol (2003) 1.00
Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med (1981) 0.99
Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders. Clin Nutr (2001) 0.99
Presence of a nonsplenic platelet pool. Blood (1977) 0.99
Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer (1999) 0.99
[Colorectal cancer in pregnancy. A case report]. G Chir (1999) 0.98
A new mechanism for tumor induced platelet aggregation. Comparison with mechanisms shared by other tumor with possible pharmacologic strategy toward prevention of metastases. Int J Cancer (1983) 0.97
Characterization of the myoglobin and its coding gene of the mollusc Biomphalaria glabrata. J Biol Chem (1998) 0.97
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood (1998) 0.96
Crossed immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Biol Chem (1980) 0.96
Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci (1997) 0.96
Effect of dose formulation on isoniazid absorption in two young children. Pediatrics (1986) 0.96
Genetic characterization of pepP, which encodes an aminopeptidase P whose deficiency does not affect Lactococcus lactis growth in milk, unlike deficiency of the X-prolyl dipeptidyl aminopeptidase. Appl Environ Microbiol (1998) 0.96
Gene cloning and characterization of PepC, a cysteine aminopeptidase from Streptococcus thermophilus, with sequence similarity to the eucaryotic bleomycin hydrolase. Eur J Biochem (1994) 0.95
Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients. Ann Intern Med (1974) 0.95
Mendelian diseases among Roman Jews: implications for the origins of disease alleles. J Clin Endocrinol Metab (1999) 0.95
[Antipyretic and anti-inflammatory effects of Artemisia annua L]. Zhongguo Zhong Yao Za Zhi (1993) 0.95
Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol (1972) 0.95
Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol (1996) 0.95
A monoclonal anti-platelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. Proc Natl Acad Sci U S A (1983) 0.95
Heterogeneity of human platelets. Metabolic and kinetic evidence suggestive of young and old platelets. Ser Haematol (1971) 0.94
Lack of effect of in vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT26 colon carcinoma, Lewis lung carcinoma, or B16 amelanotic melanoma cells. Cancer Res (1984) 0.94
Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. Blood (1993) 0.93
Micronuclei in lymphocytes of young patients under antileukemic therapy. Mutat Res (1991) 0.92
Heterogeneity of human fibrinogen: possible relation to proteolysis by thrombin and plasmin as studies by SDS-polyacrylamide gel electrophoresis. Biochem Biophys Res Commun (1970) 0.92